Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials. [PDF]
Prochaska J +4 more
europepmc +1 more source
Mitigating the risks: addressing smoking cessation in thyroid eye disease. [PDF]
Karimi N +6 more
europepmc +1 more source
A gender perspective of smoking cessation's health and economic value in Jordanian women: using cost effectiveness model. [PDF]
Madae'en S +7 more
europepmc +1 more source
Cytisinicline vs. Varenicline in Tobacco Addiction: A Literature Review Focused on Emotional Regulation, Psychological Symptoms, and Mental Health. [PDF]
Fraile-Martínez Ó +6 more
europepmc +1 more source
Interventions for quitting vaping. [PDF]
Butler AR +12 more
europepmc +1 more source
Disproportionality analysis of taste disorders using the FDA adverse event reporting system and Japanese adverse drug event report databases. [PDF]
Kyotani Y, Nakahira K, Yoshizumi M.
europepmc +1 more source
Drug-induced risk of depression: A 20-year real-world pharmacovigilance analysis based on the FAERS database. [PDF]
Xiang X, Yin L, Deng C, Feng Q.
europepmc +1 more source
Efficacy and safety of anti-inflammatory drug-assisted treatment of symptoms in patients with schizophrenia: a meta-analysis. [PDF]
Li H, Shen H, Duan X, Guo M, Liu X.
europepmc +1 more source
A summary of the guidance relating to four lifestyle risk factors for recurrent stroke: tobacco use, alcohol consumption, diet and physical activity [PDF]
Brownlee, Margaret +4 more
core

